Standard Deliberation

Discussion on the criteria for successful method verification and transfer*

Expand
  • 1. NMPA Key Lab for Quality Research and Evaluation of Chemical Drug,National Institutes for Food and Drug Control,Beijing 102629,China;
    2. Yantai University,Yantai 264003,China

Revised date: 2020-07-23

  Online published: 2024-07-15

Abstract

Objective: To explore the criteria for successful method verification and transfer. Methods: Combining with advancements in methodological research in recent years,especially the advancements in the application of statistics in this field,the unclear issues were analyzed in the current guidelines or literature about methods verification/transfer,and the criteria were discussed for successful method verification and transfer by introducing predictive interval,tolerance interval and method capability index. Results: Analysis method verification/transfer protocol followed the protocol of method validation,and the experimental design only required the experimenter to repeat the operation independently according to the requirements of method validation. If the reported value obtained was within the prediction interval of the method validation results,the method verification/transfer could be judged successful. If the report value exceeded the tolerance interval of method validation results,the method verification/transfer could be judged unsuccessful. If the report value was between the tolerance interval and the prediction interval,attention should be paid to the experimental process and further improvement should be attempted. In addition,the method capability index could also be used for determination of verification/transfer. Conclusion: When using the new experiment design mentioned here for method verification/transfer,there are obvious advantages to use the following approaches as criteria to judge whether the method verification/transfer are successful. One is comparing the reported value obtained from method verification/transfer with the prediction interval and tolerance interval from method validation and the other is assessing by calculating the method capability index. At the same time,it can effectively reduce the risk of misjudgment caused by the method verification/transfer process.

Cite this article

LI Na, GENG Ying, TAN De-jiang, YANG Hua-xin, ZHU Rong-die, MA Li, XU Hui, ZHANG Qing-sheng . Discussion on the criteria for successful method verification and transfer*[J]. Chinese Journal of Pharmaceutical Analysis, 2021 , 41(4) : 675 -680 . DOI: 10.16155/j.0254-1793.2021.04.14

References

[1] USP 41-NF 36[S].2018:7671<1226>
[2] 中华人民共和国药典2020 年版.四部[S].2020:478<9099>
ChP2020.Vol Ⅳ[S].2020:478<9099>
[3] USP 41-NF 36[S].2018:7663<1224>
[4] 中华人民共和国药典2020 年版.四部[S].2020:479<9100>
ChP2020.Vol Ⅳ[S].2020:479<9100>
[5] ICH.Q7A Good Manufacturing Practice Guide for Active Pharmaceutical Ingredients[S].2000
[6] ISO/IEC 17025:2005 General Requirements for the Competence of Testing and Calibration Laboratories[S].SO/IEC 17025:2005 General Requirements for the Competence of Testing and Calibration Laboratories[S].2005
[7] GB/T 27417-2017 合格评定化学分析方法确认和验证指南[S].2017
GB/T 27417-2017 Conformity Assessment-Guidance on Validation and Verification of Chemical Analytical Methods[S].2017
[8] PA/PH/OMCL(13)82 2R.Validation of Analytical Procedures,OMCL Network of the Council of Europe General Document[S/OL].2014[2020-12-04].https://www.edqm.eu/medias/fichiers/validation_of_analytical_procedures_paphomcl_13_82_2r.pdf
[9] WEITZEL MLJ,LEE SM,SMOOT M,et al.How to Meet ISO 17025 Requirements for Method Verification[EB/OL].2007[2020-12-04].https://www.aoac.org/resources/alacc-method-verification/
[10] 许明哲,黄宝斌,杨青云,等.分析方法转移内容介绍[J].药物分析杂志,2015,35(1):176
XU MZ,HUANG BB,YANG QY,et al.Introduction to the concept and content of analytical method transfer[J].Chin J Pharm Anal,2015,35(1):176
[11] 许明哲,黄宝斌,杨青云,等.分析方法确认内容介绍[J].药物分析杂志,2015,35(1):183
XU MZ,HUANG BB,YANG QY,et al.Analytical method verification in China OMCLs[J].Chin J Pharm Anal,2015,35(1):183
[12] 钟丽君,陈思,田军.分析方法确认的介绍和建议[J].药物分析杂志,2019,39(5):945
ZHONG LJ,CHEN S,TIAN J.Introduction and suggestion on analytical method verification[J].Chin J Pharm Anal,2019,39(5):945
[13] NEUMANN WJ.Method Validation vs.Verification vs.Transfer:What's the Difference?[EB/OL].2019[2020-12-04].https://cptclabs.com/method-validation-vs-verification/
[14] USP 41-NF 36[S].2018:7622<1210>
[15] USP 41-NF 36[S].2018:7665<1225>
[16] USP 41-NF 36[S].2018:6706<1010>
[17] 冯国双,朱容蝶,谭德讲,等.药品检验中等效区间的确定方法与应用[J].中华医学杂志,2017,97(48):3835
FENG GS,ZHU RD,TAN DJ,et al.Determination method and application of equivalent interval in drug testing[J].Natl Med J China,2017,97(48):3835
[18] 张横,谭德讲.统计区间的作用及在药品质量控制中的应用[J].药物分析杂志,2013,33(11):1840
ZHANG H,TAN DJ.The effects of intervals and their application in pharmaceutical quality control[J].Chin J Pharm Anal,2013,33(11):1840
[19] 谭德讲,朱容蝶,耿颖,等.判断定量类理化分析方法满足预期用途的标准探讨[J].药物分析杂志,2019,39(2):196
TAN DJ,ZHU RD,GENG Y,et al.Discussion about the criteria of quantitative physicochemical analytical methods for satisfying their intended use[J].Chin J Pharm Anal,2019,39(2):196
[20] 马莉,杨亚宗,张云雷,等.含量测定类方法验证中的统计学评价[J].药物分析杂志,2019,39(2):207
MA L,TANG ZY,ZHANG YL,et al.Statistical evaluation of method validation for quantitation of major components[J].Chin J Pharm Anal,2019,39(2):207
[21] 朱容蝶,耿颖,谭德讲,等.方法验证性能参数的获取和评价新方式探讨[J].药物分析杂志,2019,39(2):202
ZHU RD,GENG Y,TAN DJ,et al.Discussion about new approach for acquisition and evaluation of performance parameters of method validation[J].Chin J Pharm Anal,2019,39(2):202
[22] 谭德讲,隋思涟,朱容蝶,等.理化方法验证统计分析软件的设计与功能[J].药物分析杂志,2019,39(2):223
TAN DJ,SUI SL,ZHU RD,et al.Design and function of statistical software for validation of analytical procedures[J].Chin J Pharm Anal,2019,39(2):223
Outlines

/